To improve survival rates and the quality of survival in young cancer patients and to find ways to prevent cancer in the future.
We currently fund more than 60 research projects at centres of excellence around the UK. These projects are investigating a broad range of childhood cancers – helping us to better understand these diseases and to find more effective, less toxic ways of treating them.
Through our investment in research, we are taking forward our understanding of childhood cancer, to give new insights into ways of treating young patients with even the most difficult forms of cancer. We are working to drive up the survival rate still further by developing more effective curative therapies with fewer toxic side effects.
We share stories from families affected by childhood cancer, we also have guest blogs written by parents to help families and children affected by childhood cancer. We welcome guest bloggers and researchers to share their experiences, so we can provide comfort and support to parents and families.
When a child is diagnosed with cancer, it can be a frightening experience for the whole family. Treatment normally starts immediately, is often given many miles from home and can last for several years.
At Children with Cancer UK, we fund innovative welfare projects to provide better care and practical support for young cancer patients and their families.
One of the greatest medical success stories of the last century is the amazing growth in the survival from childhood cancer. Fifty years ago, only a quarter of children diagnosed with cancer survived. Today, more than 80% of young patients can be successfully treated.
However, cancer still claims the lives of around 250 children every year in the UK. And unfortunately the children who survive may be left with serious health and developmental problems as a result of the intensive treatments used to save their young lives.
Through our investment in research, we are working to drive up the survival rate still further by developing more effective curative therapies with fewer toxic side effects.Find out about our research